Inocras is a company for whole genome sequencing, providing a comprehensive view of a patient's entire genetic profile through WGS analysis and interpretation. Focusing on cancer and rare diseases, we aspire to fundamentally change how the world treats genetically driven diseases with an unsurpassed WGS databank and an integrated platform for generating, collecting, and analyzing genomic data.
Location: United States, California, San Diego
Total raised: $31M
Investors 1
| Date | Name | Website |
| 17.05.2024 | Dunamu &am... | dunamupart... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.08.2026 | - | $31M | IMM Invest... |
Mentions in press and media 13
| Date | Title | Description |
| 05.08.2026 | Inocras Fuels U.S. Precision Oncology Push with $31M Capital Infusion | Inocras, a San Diego bioinformatics leader, secured $31M in Series B-3 financing, raising its total capital to $100M. This investment fuels rapid U.S. expansion of its CLIA/CAP-certified whole-genome sequencing (WGS) and automated analytics... |
| 05.08.2026 | Inocras Closes $31M in Oversubscribed Series B-3 | SAN DIEGO, CA, Inocras, a bioinformatics-led company, announced that it has raised $31 million in an oversubscribed Series B-3 financing. >> Click here for more funding data on Inocras >> To export Inocras funding data to PDF a... |
| 03.08.2026 | Inocras Closes $31M for Whole-Genome Bioinformatics Platform | What You Should Know San Diego-based bioinformatics company Inocras Inc. closed an oversubscribed $31M Series B-3 financing round, bringing its total capital raised to approximately $100M. The funding round was supported by strategic invest... |
| 03.08.2026 | Inocras Closes $31M Series B-3 Financing | Inocras Inc., a San Diego, CA-based bioinformatics-led company leveraging whole-genome data and proprietary analytics to deliver curated insights, raised $31m in Series B-3 financing. Backers included NDS Corporation, Aimed Bio, IMM Investm... |
| 03.08.2026 | Inocras Raises $31 Million In Oversubscribed Series B-3, Bringing Total Funding To $100 Million | Inocras has raised $31 million in an oversubscribed Series B-3 financing round to expand its whole-genome sequencing and bioinformatics platform in the United States. The financing brings the San Diego-based company’s total funding to appro... |
| 10.07.2026 | [Inocras] 이노크라스, 패널 없이 초정밀 암세포 검출 가능한 'MRDVision' 출시 | - |
| 10.07.2026 | [Inocras] 이노크라스, 일본 국립암센터와 임상 결과 국제 무대서 공개 | - |
| 10.07.2026 | [Inocras] Inocras와 SPI, 일본 유전체 의학 발전 위한 AI 기반 전장유전체 분석 협력 개시 | - |
| 29.10.2024 | The Future of Health: Unraveling the Mysteries of Genomics and Rare Diseases | In the world of medicine, the future is often painted in broad strokes. But what if we could zoom in, dissect the canvas, and see the intricate details? The realms of genomics and rare diseases are like uncharted territories, waiting for ex... |
| 29.10.2024 | Decoding DNA: Viewpoint with Dennis Quaid teams with Inocras Inc. to discuss personalized genomics | Inocras Inc. Have you ever wondered what your DNA holds? The answers to your health, ancestry, and even traits like height and eye color could all be hidden within the code of your genes. MIAMI, Oct. 29, 2024 /PRNewswire-PRWeb/ -- An upcomi... |
Show more